Error
Jump to navigation
Jump to search
Pages in category "Autoimmune diseases"
The following 200 pages are in this category, out of 713 total.
(previous page) (next page)L
- Langerhans cell histiocytosis laboratory tests
- Langerhans cell histiocytosis medical therapy
- Langerhans cell histiocytosis MRI
- Langerhans cell histiocytosis natural history
- Langerhans cell histiocytosis other diagnostic studies
- Langerhans cell histiocytosis other imaging findings
- Langerhans cell histiocytosis overview
- Langerhans cell histiocytosis pathophysiology
- Langerhans cell histiocytosis physical examination
- Langerhans cell histiocytosis primary prevention
- Langerhans cell histiocytosis risk factors
- Langerhans cell histiocytosis screening
- Langerhans cell histiocytosis secondary prevention
- Langerhans cell histiocytosis surgery
- Latent autoimmune diabetes
- Pathophysiology of multiple sclerosis
- Linear immunoglobulin A dermatosis
- List of multiple sclerosis organizations
- Lupus nephritis
- Lupus nephritis case study one
- Lupus nephritis cost-effectiveness of therapy
- Lupus nephritis differential diagnosis
- Lupus nephritis epidemiology and demographics
- Lupus nephritis future or investigational therapies
- Lupus nephritis natural history, complications and prognosis
- Lupus nephritis pathophysiology
- Lupus nephritis staging
- Lupus vasculitis
M
- Marburg multiple sclerosis
- McDonald criteria
- Microscopic polyangiitis(patient information)
- Morphea
- Multiple sclerosis (patient information)
- Multiple sclerosis case study one
- Multiple sclerosis cost-effectiveness of therapy
- Multiple sclerosis future or investigational therapies
- Multiple Sclerosis organizations
- Myasthenia gravis causes
- Myasthenia gravis classification
- Myasthenia gravis epidemiology and demographics
- Myasthenia gravis historical perspective
- Myasthenia gravis history and symptoms
- Myasthenia gravis overview
- Myasthenia gravis pathophysiology
- Myasthenia gravis physical examination
P
- Pemphigoid
- Pemphigoid gestationis
- Pemphigus
- Polychondritis
- Polymyositis and dermatomyositis differential diagnosis
- Primary biliary cirrhosis case study one
- Primary biliary cirrhosis future or investigational therapies
- Primary sclerosing cholangitis chest x ray
- Primary sclerosing cholangitis laboratory tests
- Psoriatic arthritis
- Psoriatic arthritis causes
- Psoriatic arthritis classification
- Psoriatic arthritis CT
- Psoriatic arthritis diagnostic study of choice
- Psoriatic arthritis differential diagnosis
- Psoriatic arthritis echocardiography and ultrasound
- Psoriatic arthritis electrocardiogram
- Psoriatic arthritis epidemiology and demographics
- Psoriatic arthritis historical perspective
- Psoriatic arthritis history and symptoms
- Psoriatic arthritis laboratory tests
- Psoriatic arthritis medical therapy
- Psoriatic arthritis MRI
- Psoriatic arthritis natural history, complications and prognosis
- Psoriatic arthritis other diagnostic studies
- Psoriatic arthritis overview
- Psoriatic arthritis pathophysiology
- Psoriatic arthritis physical examination
- Psoriatic arthritis Primary prevention
- Psoriatic arthritis risk factors
- Psoriatic arthritis screening
- Psoriatic arthritis secondary prevention
- Psoriatic arthritis surgical therapy
- Psoriatic arthritis x ray
R
- Rapidly progressive glomerulonephritis diagnostic study of choice
- Rapidly progressive glomerulonephritis risk factors
- Rapidly progressive glomerulonephritis secondary prevention
- Rapidly progressive glomerulonephritis surgery
- Raynaud's phenomenon
- Raynaud's phenomenon case study one
- Raynaud's phenomenon causes
- Raynaud's phenomenon cost-effectiveness of therapy
- Raynaud's phenomenon differential diagnosis
- Raynaud's phenomenon epidemiology and demographics
- Raynaud's phenomenon future or investigational therapies
- Raynaud's phenomenon history and symptoms
- Raynaud's phenomenon laboratory findings
- Raynaud's phenomenon medical therapy
- Raynaud's phenomenon natural history, complications and prognosis
- Raynaud's phenomenon other diagnostic studies
- Raynaud's phenomenon overview
- Raynaud's phenomenon pathophysiology
- Raynaud's phenomenon physical examination
- Raynaud's phenomenon primary prevention
- Raynaud's phenomenon risk factors
- Reactive arthritis case study one
- Reactive arthritis cost-effectiveness of therapy
- Reactive arthritis differential diagnosis
- Reactive arthritis future or investigational therapies
- Reactive arthritis natural history
- Reactive arthritis other imaging findings
- Reynolds syndrome
- Rheumatoid arthritis
- Rheumatoid arthritis (patient information)
- Rheumatoid arthritis case study 1
- Rheumatoid arthritis causes
- Rheumatoid arthritis CT
- Rheumatoid arthritis diagnostic criteria
- Rheumatoid arthritis differential diagnosis
- Rheumatoid arthritis epidemiology and demographics
- Rheumatoid arthritis future or investigational therapies
- Rheumatoid arthritis historical perspective
- Rheumatoid arthritis history and symptoms
- Rheumatoid arthritis laboratory tests
- Rheumatoid arthritis medical therapy
- Rheumatoid arthritis natural history
- Rheumatoid arthritis natural history, complications and prognosis
- Rheumatoid arthritis overview
- Rheumatoid arthritis pathophysiology
- Rheumatoid arthritis physical examination
- Rheumatoid arthritis risk factors
- Rheumatoid arthritis screening
- Rheumatoid arthritis x ray
S
- Sandbox:Dressler's syndrome
- Schilder's disease
- Scleroderma
- Scleroderma case study one
- Scleroderma cost-effectiveness of therapy
- Scleroderma differential diagnosis
- Scleroderma future or investigational therapies
- Scleroderma Research Foundation
- Scleromyositis
- Sjögren's syndrome case study one
- Sjögren's syndrome cost-effectiveness of therapy
- Sjögren's syndrome future or investigational therapies
- Spondylitis
- Susac's syndrome
- Swank Multiple Sclerosis Diet
- Sympathetic ophthalmia
- Systemic lupus erythematosus
- Systemic lupus erythematosus case study one
- Systemic lupus erythematosus causes
- Systemic lupus erythematosus classification scheme
- Systemic lupus erythematosus cost-effectiveness of therapy
- Systemic lupus erythematosus criteria
- Systemic lupus erythematosus CT
- Systemic lupus erythematosus differential diagnosis
- Systemic lupus erythematosus echocardiography or ultrasound
- Systemic lupus erythematosus electrocardiogram
- Systemic lupus erythematosus epidemiology and demographics
- Systemic lupus erythematosus future or investigational therapies
- Systemic lupus erythematosus historical perspective
- Systemic lupus erythematosus history and symptoms
- Systemic lupus erythematosus laboratory tests
- Systemic lupus erythematosus Lupus and Quality of Life
- Systemic lupus erythematosus medical therapy
- Systemic lupus erythematosus MRI
- Systemic lupus erythematosus natural history
- Systemic lupus erythematosus non pharmacological treatment
- Systemic lupus erythematosus other imaging findings
- Systemic lupus erythematosus pathophysiology
- Systemic lupus erythematosus primary prevention
- Systemic lupus erythematosus risk factors
- Systemic lupus erythematosus screening
- Systemic lupus erythematosus secondary prevention
- Systemic lupus erythematosus surgery
- Systemic lupus erythematosus x ray
- Systemic primary carnitine deficiency
T
- Therapies under investigation for multiple sclerosis
- Thrombotic thrombocytopenic purpura
- Thrombotic thrombocytopenic purpura (patient information)
- Thrombotic thrombocytopenic purpura case study one
- Thrombotic thrombocytopenic purpura causes
- Thrombotic thrombocytopenic purpura cost-effectiveness of therapy
- Thrombotic thrombocytopenic purpura CT
- Thrombotic thrombocytopenic purpura differential diagnosis
- Thrombotic thrombocytopenic purpura future or investigational therapies
- Thrombotic thrombocytopenic purpura historical perspective
- Thrombotic thrombocytopenic purpura history and symptoms
- Thrombotic thrombocytopenic purpura laboratory findings
- Thrombotic thrombocytopenic purpura MRI
- Thrombotic thrombocytopenic purpura natural history, complications and prognosis
- Thrombotic thrombocytopenic purpura other diagnostic studies
- Thrombotic thrombocytopenic purpura other imaging findings
- Thrombotic thrombocytopenic purpura overview
- Thrombotic thrombocytopenic purpura pathophysiology
- Thrombotic thrombocytopenic purpura physical examination
- Thrombotic thrombocytopenic purpura risk factors
- Transverse myelitis (patient information)
- Transverse myelitis case study one
- Transverse myelitis cost-effectiveness of therapy
- Transverse myelitis CT
- Transverse myelitis future or investigational therapies